UniPharma Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	46.12	58.68	68.64	63.76	75.96	74.59
Short-Term Investments	98.5	98.5	98.5	98.5	99.5	113.5
Cash & Short-Term Investments	144.62	157.18	167.14	162.26	175.46	188.09
Cash Growth	5.01%	-5.96%	3.01%	-7.52%	-6.72%	-6.18%
Accounts Receivable	15.79	16.72	21.07	34.1	22.68	24.17
Other Receivables	0.25	0.13	0.18	0	0.3	0.44
Receivables	16.04	16.86	21.25	34.11	22.98	24.6
Inventory	27.75	22.27	28.94	31.05	35.94	25.66
Prepaid Expenses	-	-	0.06	0.32	-	-
Other Current Assets	4.99	3.71	8.83	10.56	27.01	3.1
Total Current Assets	193.4	200.01	226.23	238.28	261.39	241.45
Property, Plant & Equipment	21.11	23.79	11.57	8.73	13.46	46.89
Long-Term Investments	66.56	94.3	101.26	73.58	59.09	77.64
Other Intangible Assets	3.3	3.58	1.94	2.22	2.53	36.58
Other Long-Term Assets	7.25	7.3	9.07	9.77	11.71	13.01
Total Assets	291.61	328.98	350.07	332.57	348.18	415.57
Accounts Payable	14.01	14.49	22.25	6.09	27.66	2.22
Accrued Expenses	-	-	-	0.59	-	-
Current Portion of Leases	3.69	3.71	0.27	3.26	3.46	5.67
Current Unearned Revenue	2.41	2.57	2.72	3.12	2.41	2.55
Other Current Liabilities	11.15	12.39	11.87	15.71	13.27	14.72
Total Current Liabilities	31.25	33.15	37.12	28.78	46.8	25.15
Long-Term Leases	9.12	11.07	-	0.27	3.53	11.16
Other Long-Term Liabilities	-	-	0.29	0.29	0.29	0.29
Total Liabilities	40.37	44.22	37.4	29.33	50.61	36.59
Common Stock	355.01	355.01	355.01	355.01	355.01	355.01
Additional Paid-In Capital	0.38	0.38	0.38	0.38	17.94	69.91
Retained Earnings	-111.88	-88.93	-60.92	-40.34	-51.39	-36.44
Treasury Stock	-	-	-	-	-3.91	-3.91
Comprehensive Income & Other	7.74	18.29	18.2	-11.8	-20.08	-5.6
Shareholders' Equity	251.24	284.75	312.67	303.24	297.57	378.98
Total Liabilities & Equity	291.61	328.98	350.07	332.57	348.18	415.57
Total Debt	12.8	14.78	0.27	3.53	6.99	16.82
Net Cash (Debt)	131.82	142.4	166.87	158.73	168.46	171.26
Net Cash Growth	8.85%	-14.67%	5.13%	-5.78%	-1.63%	-3.80%
Net Cash Per Share	3.71	4.01	4.70	4.47	4.79	4.87
Filing Date Shares Outstanding	35.5	35.5	35.5	35.5	35.2	35.2
Total Common Shares Outstanding	35.5	35.5	35.5	35.5	35.2	35.2
Working Capital	162.15	166.86	189.11	209.51	214.59	216.3
Book Value Per Share	7.08	8.02	8.81	8.54	8.45	10.77
Tangible Book Value	247.94	281.17	310.73	301.03	295.04	342.4
Tangible Book Value Per Share	6.98	7.92	8.75	8.48	8.38	9.73
Machinery	29.2	28.62	28.14	20.03	19.88	46.88
Leasehold Improvements	-	-	-	-	0.38	5.02

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.